查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1616685

腹腔镜器材市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Laparoscopic Instruments Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球腹腔镜器械市场估值为143亿美元，预计2024年至2032年间复合年增长率为9.1%。推动。对这些手术技术日益增长的需求推动了市场的扩张，这些技术具有缩短恢復时间和最小化疤痕等优点。随着肥胖和相关健康问题的日益流行，减重手术显着增长。此外，胃肠道疾病和癌症等慢性病的发生率不断上升，增加了对腹腔镜手术的需求，从而增强了现代手术实践中对创新器械的需求。

腹腔镜器械是微创手术中使用的重要工具，在微创手术中会形成小切口，并使用摄影机指导外科医生。该技术可在对周围组织造成最小损伤的情况下进行精确手术，从而提高患者的治疗效果。该市场按产品类型细分，腹腔镜在 2023 年处于领先地位，收入约为 57 亿美元。腹腔镜对于在手术过程中提供视觉清晰度至关重要，并用于各种专业，包括普通外科、妇科、泌尿科和减肥科，这有助于其在市场上占据主导地位。

从应用程式来看，2023年一般外科细分市场占多数份额，收入达54亿美元。此细分市场涵盖阑尾切除术、疝气修补和胃肠手术等众多手术，由于腹腔镜器械的广泛使用，推动了对腹腔镜器械的巨大需求。一般外科手术中微创技术的采用进一步增加了对这些工具的需求。在使用方面，一次性器材在 2023 年以 52.6% 的收入份额引领市场。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 143 亿美元
预测值 320 亿美元
复合年增长率 9.1%

按最终用途划分，医院占据市场主导地位，贡献了 97 亿美元的收入。医院需要进行各种复杂的手术，需要先进的设备并处理大量的患者，这增加了对腹腔镜器械的需求。从地区来看，由于慢性病发病率高和对微创手术的偏好，北美在 2023 年的收入将达到 65 亿美元。在强大的医疗基础设施和有利的报销政策的支持下，美国市场预计将大幅成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 腹腔镜手术器械的技术进步
      • 微创手术日益受到青睐
      • 腹腔镜手术数量不断增加
      • 强大的产品管线
    • 产业陷阱与挑战
      • 设备成本高
      • 严格规定
  • 成长潜力分析
  • 技术景观
  • 监管环境
  • 未来市场趋势
  • 报销场景
  • 差距分析
    • 我们
    • 加拿大
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 中国
    • 日本
    • 印度
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 战略定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 腹腔镜
    • 视讯腹腔镜
    • 纤维腹腔镜
  • 能源设备
  • 气腹机
  • 抽吸系统
  • 封闭装置
  • 手用仪器
  • 存取装置
  • 腹腔镜配件

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 妇科手术
  • 泌尿科
  • 大肠直肠手术
  • 减重手术
  • 一般外科
  • 小儿外科
  • 其他应用

第 7 章：市场估计与预测：按用途分类，2021 - 2032 年

  • 主要趋势
  • 一次性的
  • 可重复使用的

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Aesculap, Inc. (B. Braun)
  • Apollo Endosurgery
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical Inc.
  • Ethicon Inc. (Johnson & Johnson)
  • Intuitive Surgical
  • Karl Storz GmbH
  • Medtronic Plc (Covidien)
  • Microline Surgical
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew Inc.
  • Stryker Corporation
简介目录
Product Code: 1954

The Global Laparoscopic Instruments Market was valued at USD 14.3 billion in 2023 and is projected to grow at a CAGR of 9.1% between 2024 and 2032. This growth is primarily driven by the rising number of laparoscopic procedures and the increasing preference for minimally invasive surgeries. The market's expansion is fueled by the growing need for these surgical techniques, which offer benefits like reduced recovery time and minimal scarring. With the increasing prevalence of obesity and related health issues, bariatric surgeries have seen significant growth. Furthermore, the rising occurrence of chronic conditions such as gastrointestinal disorders and cancers has heightened the need for laparoscopic surgeries, reinforcing the demand for innovative instruments in modern surgical practices.

Laparoscopic instruments are essential tools used in minimally invasive surgeries, where small incisions are made, and a camera is used to guide the surgeon. This technique allows for precise operations with minimal damage to surrounding tissues, enhancing patient outcomes. The market is segmented by product type, with laparoscopes leading in 2023 with a revenue of around USD 5.7 billion. Laparoscopes are vital in providing visual clarity during surgeries and are used across various specialties, including general surgery, gynecology, urology, and bariatrics, contributing to their dominance in the market.

By application, the general surgery segment held the majority share in 2023, generating USD 5.4 billion in revenue. This segment covers numerous procedures like appendectomies, hernia repairs, and gastrointestinal surgeries, driving significant demand for laparoscopic instruments due to their widespread use. The adoption of minimally invasive techniques in general surgery further boosts the demand for these tools. In terms of usage, disposable instruments led the market with a 52.6% revenue share in 2023. Disposable tools offer the advantage of reducing the risk of cross-contamination, ensuring compliance with strict sterility standards in healthcare settings.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$14.3 Billion
Forecast Value$32 Billion
CAGR9.1%

By end-use, hospitals dominated the market, contributing USD 9.7 billion in revenue. Hospitals cater to a wide range of complex surgeries, demanding advanced equipment and handling a higher volume of patients, which fuels the need for laparoscopic instruments. Regionally, North America accounted for USD 6.5 billion in revenue in 2023, driven by a high incidence of chronic diseases and a preference for minimally invasive surgeries. The U.S. market is projected to grow significantly, supported by a robust healthcare infrastructure and favorable reimbursement policies.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancements in laparoscopic surgical instruments
      • 3.2.1.2 Growing preference for minimally invasive surgery
      • 3.2.1.3 Increasing number of laparoscopic procedures
      • 3.2.1.4 Strong product pipeline
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of the devices
      • 3.2.2.2 Stringent regulations
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Future market trends
  • 3.7 Reimbursement scenario
  • 3.8 Gap analysis
  • 3.9 Number of gynecological laparoscopic procedures by 10 major markets, 2021 - 2032
    • 3.9.1 U.S.
    • 3.9.2 Canada
    • 3.9.3 Germany
    • 3.9.4 UK
    • 3.9.5 France
    • 3.9.6 Spain
    • 3.9.7 Italy
    • 3.9.8 China
    • 3.9.9 Japan
    • 3.9.10 India
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Strategic positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Laparoscopes
    • 5.2.1 Video laparoscopes
    • 5.2.2 Fiber laparoscopes
  • 5.3 Energy devices
  • 5.4 Insufflators
  • 5.5 Suction systems
  • 5.6 Closure devices
  • 5.7 Hand instruments
  • 5.8 Access devices
  • 5.9 Laparoscopic accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Procedures)

  • 6.1 Key trends
  • 6.2 Gynecological surgery
  • 6.3 Urological surgery
  • 6.4 Colorectal surgery
  • 6.5 Bariatric surgery
  • 6.6 General surgery
  • 6.7 Pediatric surgery
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Usage, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Disposable
  • 7.3 Reusable

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Aesculap, Inc. (B. Braun)
  • 10.2 Apollo Endosurgery
  • 10.3 Boston Scientific Corporation
  • 10.4 CONMED Corporation
  • 10.5 Cook Medical Inc.
  • 10.6 Ethicon Inc. (Johnson & Johnson)
  • 10.7 Intuitive Surgical
  • 10.8 Karl Storz GmbH
  • 10.9 Medtronic Plc (Covidien)
  • 10.10 Microline Surgical
  • 10.11 Olympus Corporation
  • 10.12 Richard Wolf GmbH
  • 10.13 Smith & Nephew Inc.
  • 10.14 Stryker Corporation